Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OGEN

Oragenics Inc

Jun 08 • 09:59AM ET

0.6048

+0.0109 1.83 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: BCDA LNAI NEUP APRE BIVI CALC CVM GOVX KAPA KPRX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.12	Insider Own	0.47%	Shs Outstand	4.51M	Perf Week	-0.02%
Market Cap	2.73M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.98%	Shs Float	4.49M	Perf Month	-1.33%
Enterprise Value	-3.32M	PEG	-	EPS next Q	-	Inst Own	4.22%	Short Float	14.62%	Perf Quarter	-37.01%
Income	-9.83M	P/S	-	EPS this Y	-	Inst Trans	-0.65%	Short Ratio	5.11	Perf Half Y	-28.97%
Sales	0.00M	P/B	0.43	EPS next Y	-	ROA	-173.03%	Short Interest	0.66M	Perf YTD	-22.77%
Book/sh	1.41	P/C	0.45	EPS next 5Y	-	ROE	-311.00%	52W High	5.24 -88.46%	Perf Year	-85.87%
Cash/sh	1.35	P/FCF	-	EPS past 3/5Y	72.24% 64.78%	ROIC	-158.96%	52W Low	0.50 20.06%	Perf 3Y	-99.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.46% 6.96%	Perf 5Y	-99.96%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	84.00%	Oper. Margin	-	ATR (14)	0.04	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	5.73	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	49.87	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.73	EPS Q/Q	85.98%	SMA20	2.49%	Beta	1.23	Target Price	2.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-0.35%	Rel Volume	0.12	Prev Close	0.59
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-32.65%	Avg Volume	128.53K	Price	0.60
IPO	Oct 21, 2003	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,934	Change	1.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)